Immunotherapy with BCG vaccine in 30 cases of mesothelioma.
Thirty patients with malignant pleural mesothelioma who underwent BCG vaccine immunotherapy are presented. There was an improved survival rate, compared with patients treated symptomatically only. Techniques of therapy are detailed and the importance of 'tumour load' reduction and prolonged injection schedule, is stressed.
D001500:BCG Vaccine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000628:therapy*; D010997:Pleural Neoplasms / Q000628:therapy*
D001500:BCG Vaccine